Risk Assessment for Halogenated Solvents

    Volume 17, Issue 2 (March 1989)

    ISSN: 0090-3973


    Page Count: 4

    Travis, CC
    Office of Risk Analysis, Oak Ridge National Laboratory, Oak Ridge, TN


    A recent development in the cancer risk area is the advent of biologically based pharmacokinetic and pharmacodynamic models. These models allow for the incorporation of biological and mechanistic data into the risk assessment process. These advances will not only improve the risk assessment process for halogenated solvents but will stimulate and guide basic research in the biological area.

    Paper ID: JTE11099J

    DOI: 10.1520/JTE11099J

    ASTM International is a member of CrossRef.

    Title Risk Assessment for Halogenated Solvents
    Symposium , 0000-00-00
    Committee E31